23.12.2013 Views

Nordzucker_GB 03-04_E_.pd 1 - Nordzucker AG

Nordzucker_GB 03-04_E_.pd 1 - Nordzucker AG

Nordzucker_GB 03-04_E_.pd 1 - Nordzucker AG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Management Report<br />

Shareholdings Business Development<br />

in t milion<br />

Hübner-Medopharm Syral* Amino**<br />

2002 20<strong>03</strong><br />

2001/02 2002/<strong>03</strong><br />

2002 20<strong>03</strong><br />

Sales<br />

30<br />

31<br />

77<br />

168<br />

46<br />

44<br />

EBIT<br />

1<br />

2<br />

-6<br />

3<br />

3<br />

2<br />

Net income (consolidated)<br />

1<br />

1<br />

-8<br />

2<br />

2<br />

2<br />

Investment in tangible assets<br />

0<br />

1<br />

9<br />

142***<br />

3<br />

2<br />

Staff (average of financial year)<br />

229<br />

210<br />

85<br />

272<br />

346<br />

344<br />

Equity capital<br />

-4<br />

-3<br />

45<br />

44<br />

13<br />

18<br />

<strong>Nordzucker</strong> share (in percent)<br />

98%<br />

98%<br />

36%<br />

50%<br />

50%<br />

50%<br />

* Financial year ended on 30 Sept. each year<br />

2002/<strong>03</strong> figures include Staral<br />

** Sub-group Amino (Amino GmbH, esparma<br />

GmbH, S.A. Bioproducts at equity)<br />

*** Including additions from merger<br />

30<br />

The non-sugar shareholdings are<br />

coordinated within the Business<br />

Development division. The only exception<br />

is the Hübner-Medopharm group,<br />

which because of the 98-percent stake is<br />

fully consolidated. The 50-percent share<br />

holding Syral S.A. and the Amino group<br />

are accounted for in the group with their<br />

equity ratio. SweetGredients is accounted<br />

for on a pro rata basis (proportional consolidation).<br />

Hübner-Medopharm<br />

The main business of the group, in which<br />

<strong>Nordzucker</strong> holds 98 percent, is the production<br />

and marketing of natural food<br />

supplements, medical and cosmetic<br />

products. The main outlets for these<br />

products in Germany are health shops<br />

and dispensing chemists. Exports go to<br />

more than 30 countries.<br />

Satisfactory Sales and Exports<br />

The highly satisfactory development of<br />

the group continued in 20<strong>03</strong>. Although<br />

consumer reluctance also affected the<br />

health shop sector in Germany with<br />

some delay, overall sales increased by<br />

some five percent.<br />

For the dispensing chemists sector, the<br />

seven-percent drop in sales reflects the<br />

strategy of reserving tight field service<br />

resources for customers with profitable<br />

minimum sales. Innovative products<br />

specifically developed for this sector<br />

will bring about an adjustment in 20<strong>04</strong>.<br />

Exports rose by six percent and have<br />

thus continued the favourable trend of<br />

previous years. The increase was not least<br />

due to new customers attracted in non-<br />

European markets.<br />

Modernisation Programme Completed<br />

Commissioning of the new filling and<br />

packaging plant for the core and USP<br />

product ‘Silicea’ in the spring of the year<br />

20<strong>04</strong> completed the modernisation programme<br />

launched when Hübner was<br />

taken over.<br />

SweetGredients<br />

In line with the <strong>Nordzucker</strong> policy of<br />

developing its core activities in a changing<br />

market, <strong>Nordzucker</strong> founded the<br />

company SweetGredients in 20<strong>03</strong>. On

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!